Hartford Financial Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.85K | Sell |
1,000
-500
| -33% | -$4.43K | ﹤0.01% | 285 |
|
|
2025
Q1 | $11.7K | Hold |
1,500
| – | – | ﹤0.01% | 284 |
|
|
2024
Q4 | $15.8K | Hold |
1,500
| – | – | ﹤0.01% | 275 |
|
|
2024
Q3 | $19.7K | Hold |
1,500
| – | – | ﹤0.01% | 269 |
|
|
2024
Q2 | $21.1K | Buy |
1,500
+500
| +50% | +$7.03K | ﹤0.01% | 270 |
|
|
2024
Q1 | $16.9K | Hold |
1,000
| – | – | ﹤0.01% | 285 |
|
|
2023
Q4 | $14.1K | Hold |
1,000
| – | – | ﹤0.01% | 292 |
|
|
2023
Q3 | $10.3K | Hold |
1,000
| – | – | ﹤0.01% | 301 |
|
|
2023
Q2 | $16.5K | Hold |
1,000
| – | – | ﹤0.01% | 256 |
|
|
2023
Q1 | $9.16K | Hold |
1,000
| – | – | ﹤0.01% | 285 |
|
|
2022
Q4 | $7.16K | Hold |
1,000
| – | – | ﹤0.01% | 296 |
|
|
2022
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 308 |
|
|
2022
Q2 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 349 |
|
|
2022
Q1 | $7K | Buy |
+1,000
| New | +$7K | ﹤0.01% | 308 |
|